Mercia Fund Management made the investment.
The company intends to use the funds to grow the team and other resources required to build and test the initial product range.
An Aston University spin-out, Aston EyeTech allows opticians to make more accurate and consistent diagnoses of eye conditions, sell more items through greater personalization of product recommendations. For clinical trials, the software enables eye tests to be conducted more efficiently, with faster collation and analysis of results.
Led by Paul Blackburn, Executive Chairman, the company is targeting optical retailers in the UK and overseas, clinical trials organizations, domiciliary service providers and the NHS.